Achilles Therapeutics to delist ADSs from Nasdaq and deregister from SEC, calling for liquidation with General Meeting on March 20, 2025.
On February 28, 2025, Achilles Therapeutics plc (NASDAQ: ACHL) announced its decision to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq and deregister the ADSs from the SEC under Section 12(b) of the Exchange Act. The company will hold a General Meeting on March 20, 2025, to seek shareholder approval for starting a members’ voluntary liquidation. This delisting is part of the process related to the planned liquidation.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments